Historical record - last NADAC effective date: 8/18/2021
Product Information
EZETIMIBE-SIMVASTATIN 10-10 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.2299 per EA under NDC 69238115509. Its NADAC has been published 180 times since Mar 14, 2018.
FDA first approved this application on Nov 21, 2017.
Strength
10; 10 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238115509
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208831FDA Approved
11/21/2017
On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has been published 180 times since Mar 14, 2018, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2299 per EA |
|---|---|
| All-time high | $3.1958 (Mar 14, 2018) |
| All-time low | $0.6256 (Dec 23, 2020) |
| Median price | $1.6140 |
| Average price | $1.6552 |
| Largest weekly change | +42.0% (Jun 23, 2021) |
| Weeks tracked | 180 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-61.5%
Last surveyed Aug 18, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-10 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $1.2299 per EA (NDC 69238115509), effective Aug 18, 2021.
How has the price of EZETIMIBE-SIMVASTATIN 10-10 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has declined 61.5%. It has been tracked across 180 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-10 MG?
Since Mar 14, 2018, the NADAC for EZETIMIBE-SIMVASTATIN 10-10 MG has ranged from a low of $0.6256 (Dec 23, 2020) to a high of $3.1958 (Mar 14, 2018), with a median of $1.6140 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-10 MG?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-10 MG, is $0.3246 per EA — about 74% below EZETIMIBE-SIMVASTATIN 10-10 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-10 MG?
EZETIMIBE-SIMVASTATIN 10-10 MG (NDC 69238115509) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.